Clinical Trial

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-10-20; most recent amendment 2026-03-18.
Status change: Not Yet Recruiting → Recruiting 2021-11-26
Trial Details
NCT Number NCT04597372
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborators: Johns Hopkins University
Conditions Urinary Retention Postoperative
Enrollment 154 participants
Start Date 2021-11-03
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-20